Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle

European Journal of Pharmacology

Volumn 645, Issue 1-3, 2010, Pages 158-164

  Toque, Haroldo A ^a   Mónica, Fabíola Z T ^a   Morganti, Rafael P ^a   De Nucci, Gilberto ^a   Antunes, Edson ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cyclic GMP; Nitric oxide; Soluble guanylyl cyclase; Tracheal smooth muscle

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 4 AMINO 5 CYCLOPROPYL 2 [1 (2 FLUOROBENZYL) 1H PYRAZOLO[3,4 B]PYRIDIN 3 YL]PYRIMIDINE; 4 AMINOPYRIDINE; APAMIN; BAY 4102272; CALCIUM CHLORIDE; CARBACHOL; CYCLIC NUCLEOTIDE; GLIBENCLAMIDE; GUANOSINE PHOSPHATE; GUANYLATE CYCLASE; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; POTASSIUM CHANNEL BLOCKING AGENT; ROLIPRAM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRIC FIELD; ENZYME ACTIVATION; EXTRACELLULAR CALCIUM; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE RELAXATION; TRACHEA MUSCLE;

ANIMALS; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ENZYME ACTIVATION; ENZYME ACTIVATORS; GUANYLATE CYCLASE; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; OXADIAZOLES; PYRAZOLES; PYRIDINES; QUINOXALINES; RATS; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRACHEA;

EID: 77956191927     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.07.028     Document Type: Article

References (35)

1. Baracat J.S., Teixeira C.E., Okuyama C.E., Priviero F.B., Faro R., Antunes E., De Nucci G. Relaxing effects induced by the soluble guanylyl cyclase stimulator BAY 41-2272 in human and rabbit corpus cavernosum. Eur. J. Pharmacol. 2003, 477:163-169.
2. Belik J., Hehne N., Pan J., Behrends S. Soluble guanylate cyclase-dependent relaxation is reduced in the adult rat bronchial smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 292:L699-L703.
3. Belvisi M.G., Stretton C.D., Miura M., Verleden G.M., Tadjkarimi S., Yacoub M.H., Barnes P.J. Inhibitory NANC nerves in human tracheal smooth muscle: a quest for the neurotransmitter. J. Appl. Physiol. 1992, 73:2505-2510.
4. Bernareggi M.M., Belsivi M.G., Patel H., Barnes P.J., Giembycz M.A. Anti-spasmogenic activity of isoenzymeselective phosphodiesterase inhibitors in guinea-pig trachealis. Br. J. Pharmacol. 1999, 128:327-336.
5. Boerrigter G., Costello-Boerrigter L.C., Cataliotti A., Tsuruda T., Harty G.J., Lapp H., Stasch J.P., Burnett J.C. Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure. Circulation 2003, 107:686-689.
6. Cau S.B., Dias-Junior C.A., Montenegro M.F., De Nucci G., Antunes E., Tanus-Santos J.E. Dose-dependent beneficial hemodynamic effects of BAY 41-2272 in a canine model of acute pulmonary thromboembolism. Eur. J. Pharmacol. 2008, 581:132-137.
7. Deruelle P., Grover T.R., Storme L., Abman S.H. Effects of BAY 41-2272, a soluble guanylate cyclase activator, on pulmonary vascular reactivity in the ovine fetus. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 288:L727-L733.
8. Diamond J. Role of cyclic GMP in airway smooth muscle relaxation. New Drugs in Allergy and Asthma 1993, 13-25. Birkhausser Verlag, Basel.
9. Dumitrascu R., Weissmann N., Ghofrani H.A., Dony E., Beuerlein K., Schmidt H., Stasch J.P., Gnoth M.J., Seeger W., Grimminger F., Schermuly R.T. Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling. Circulation 2006, 113:286-295.
10. Evgenov O.V., Ichinose F., Evgenov N.V., Gnoth M.J., Falkowski G.E., Chang Y., Bloch K.D., Zapol W.M. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs. Circulation 2004, 110:2253-2259.
11. Fleckenstein A., Fleckenstein-Grün G. Mechanism of action of calcium antagonists in heart and vascular smooth muscle. Eur. Heart J. 1988, 9 (suppl H:95-99.
12. Folkerts G., Nijkamp F.P. Airway epithelium: more than just a barrier!. Trends PharmacolSci. 1998, 19:334-341.
13. Garthwaite J., Southam E., Boulton C.L., Nielsen E.B., Schmidt K., Mayer B. Potent and selective inhibition of nitric-oxide-sensitive guanylyl cyclase by 1H (1, 2, 4) oxadiazolo (4, 3, a) quinoxalin-1-one. Mol. Pharmacol. 1995, 48:184-188.
14. Hamad A.M., Range S.P., Holland E., Knox A.J. Desensitization of guanylyl cyclases in cultured human airway smoothmuscle cells. Am. J. Respir. Cell Mol. Biol. 1999, 20:1087-1095.
15. + channel in the relaxation of bovine tracheal smooth muscle by glyceryl trinitrate and sodium nitroprusside. J. Pharmacol. Exp. Ther. 1992, 262:263-270.
16. Hogman M., Frostell C.G., Hedenstrom H., Hedenstierna G. Inhalation of nitric oxide modulates adult human bronchial tone. Am. Rev. Respir. Dis. 1993, 148:1474-1478.
17. Hulks G., Thomson N.C. High dose inhaled atrial natriuretic peptide is a bronchodilator in asthmatic subjects. Eur. Respir. J. 1994, 7:1593-1597.
18. Hwang T.L., Wu C.C., Teng C.M. Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea. Br. J. Pharmacol. 1998, 256:1158-1163.
19. Hwang T.L., Wu C.C., Teng C.M. YC-1 potentiates nitric oxide-induced relaxation in guinea-pig Trachea. Br. J. Pharmacol. 1999, 128:577-584.
20. Ijima S.C., Challiss R.A.J., Boyle J.P. Comparative effects of activation of soluble and particulate guanylyl cyclase on cGMP elevation and relaxation of bovine tracheal smooth muscle. Br. J. Pharmacol. 1995, 115:723-732.
21. Jones K.A., Lorenz R.R., Warner D.O., Katusic Z.S., Sieck G.C. Changes in cytosolic cGMP and calcium in airway smooth muscle relaxed by 3-morpholinosydnonimine. Am. J. Physiol. 1994, 266:L9-L16.
22. Kosarikov D.N., Lee J.M., Uversky V.N., Counts Gerber N. Role of conformational changes in the heme-dependent regulation of human soluble guanylate cyclase. J. Inorg. Biochem. 2001, 87:267-276.
23. Leung F.P., Yung L.M., Yao X., Laher I., Huang Y. Store-operated calcium entry in vascular smooth muscle. Br. J. Pharmacol. 2008, 153:846-857.
24. Lin R.J., Wu B.N., Lo Y.C., An L.M., Dai Z.K., Lin Y.T., Tang C.S., Chen I.J. A xanthine-based epithelium-dependent airway relaxant KMUP-3 (7-[2-[4-(4-nitrobenzene)piperazinyl]ethyl]-1, 3-dimethylxanthine) increases respiratory performance and protects against tumor necrosis factor-alpha-induced tracheal contraction, involving nitric oxide release and expression of cGMP and protein kinase G. J. Pharmacol. Exp. Ther. 2006, 316:709-717.
25. Nakahara T., Yunoki M., Moriuchi H., Mitani A., Sakamoto K., Ishii K. Relaxation and potentiation of cGMP-mediated response by ibudilast in bovine tracheal smooth muscle. Naunyn-Schmiedeberg's Arch. Pharmacol. 2002, 366:262-269.
26. Priviero F.B., Baracat J.S., Teixeira C.E., Claudino M.A., De Nucci G., Antunes E. Mechanisms underlying rabbit aorta relaxation by BAY 41-2272, a nitric oxide independent soluble guanylate cyclase activator. Clin. Exp. Pharmacol. Physiol. 2005, 32:728-734.
27. Sanders K.M. Mechanisms of calcium handling in smooth muscles. J. Appl. Physiol. 2001, 91:1438-1449.
28. Spina D., Page C.P. Pharmacology of airway irritability. Curr. Opin. Pharmacol. 2002, 2:264-272.
29. Stasch J.P., Hobbs A.J. NO-independent, haem-dependent soluble guanylate cyclase stimulators. Handb. Exp. Pharmacol. 2009, 191:277-308.
30. Stasch J.P., Becker E.M., Alonso-Alija C., Apeler H., Dembowsky K., Feurer A., Gerzer R., Minuth T., Perzborn E., Pleiss U., Schröder H., Schroeder W., Stahl E., Steinke W., Straub A., Schramm M. NO-independent regulatory site on soluble guanylate cyclase. Nature 2001, 410:212-215.
31. Teixeira C.E., Priviero F.B., Webb R.C. Molecular mechanisms underlying rat mesenteric artery vasorelaxation induced by the nitric oxide-independent soluble guanylyl cyclase stimulators BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl Indazole]. J. Pharmacol. Exp. Ther. 2006, 317:258-266.
32. Thomazzi S.M., Moreira J., De Nucci G., Antunes E. Inhibitory effects on human eosinophil chemotaxis in vitro by BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase. Biochem. Pharmacol. 2005, 69:875-882.
33. Worley J.F., Kotlikoff M.I. Dihydropyridine-sensitive single calcium channels in airway smooth muscle cells. Am. J. Physiol. 1990, 259:L468-L480.
34. + channels. Br. J. Pharmacol. 2004, 142:1105-1114.
35. Zhao Y., Brandish P.E., DiValentin M., Schelvis J.P., Babcock G.T., Marletta M.A. Inhibition of soluble guanylate cyclase by ODQ. Biochemistry 2000, 39:10848-10854.